Pages that link to "Q36066234"

The following pages link to Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts (Q36066234):

Displaying 50 items.

• Mitochondrial Stat3, the Need for Design Thinking (Q26750616) (← links)
• The consequences of selective inhibition of signal transducer and activator of transcription 3 (STAT3) tyrosine705 phosphorylation by phosphopeptide mimetic prodrugs targeting the Src homology 2 (SH2) domain (Q26861758) (← links)
• Targeting SH2 domains in breast cancer (Q27014674) (← links)
• STAT3 inhibitors for cancer therapy: Have all roads been explored? (Q27021266) (← links)
• A small molecule inhibitor of ETV1, YK-4-279, prevents prostate cancer growth and metastasis in a mouse xenograft model (Q27322372) (← links)
• Brevilin A, a novel natural product, inhibits janus kinase activity and blocks STAT3 signaling in cancer cells (Q28533183) (← links)
• The anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer model (Q28538542) (← links)
• Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation (Q28543632) (← links)
• Signal transducer and activator of transcription 3 (STAT3) inhibitor, S3I-201, acts as a potent and non-selective alkylating agent (Q28829622) (← links)
• Discovery of monocarbonyl curcumin-BTP hybrids as STAT3 inhibitors for drug-sensitive and drug-resistant breast cancer therapy (Q33551693) (← links)
• Therapeutic modulators of STAT signalling for human diseases (Q33684732) (← links)
• HCV infection enhances Th17 commitment, which could affect the pathogenesis of autoimmune diseases (Q33721367) (← links)
• Transcription Factor STAT3 as a Novel Molecular Target for Cancer Prevention (Q33820278) (← links)
• Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy. (Q33838824) (← links)
• Involvement of the janus kinase/signal transducer and activator of transcription signaling pathway in multiple sclerosis and the animal model of experimental autoimmune encephalomyelitis. (Q33988247) (← links)
• Identification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial library (Q34026446) (← links)
• The oncogenic potential of human cytomegalovirus and breast cancer (Q34081724) (← links)
• Withacnistin inhibits recruitment of STAT3 and STAT5 to growth factor and cytokine receptors and induces regression of breast tumours (Q34113499) (← links)
• The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury (Q34473321) (← links)
• Withaferin A Inhibits STAT3 and Induces Tumor Cell Death in Neuroblastoma and Multiple Myeloma (Q34482178) (← links)
• Changes in signal transducer and activator of transcription 3 (STAT3) dynamics induced by complexation with pharmacological inhibitors of Src homology 2 (SH2) domain dimerization (Q34552575) (← links)
• Progress towards the development of SH2 domain inhibitors (Q34581878) (← links)
• Pancreatic T cell protein-tyrosine phosphatase deficiency affects beta cell function in mice (Q34644615) (← links)
• Aberrantly activated pSTAT3-Ser727 in human endometrial cancer is suppressed by HO-3867, a novel STAT3 inhibitor. (Q34819689) (← links)
• HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer (Q34855872) (← links)
• Targeting survivin in cancer: novel drug development approaches (Q34954296) (← links)
• Protein kinase C zeta regulates human pancreatic cancer cell transformed growth and invasion through a STAT3-dependent mechanism (Q34981351) (← links)
• Development of new N-Arylbenzamides as STAT3 Dimerization Inhibitors (Q35000997) (← links)
• Combined STAT3 and BCR-ABL1 inhibition induces synthetic lethality in therapy-resistant chronic myeloid leukemia (Q35102414) (← links)
• A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3. (Q35598686) (← links)
• A Resveratrol Analogue Promotes ERKMAPK-Dependent Stat3 Serine and Tyrosine Phosphorylation Alterations and Antitumor Effects In Vitro against Human Tumor Cells (Q35681707) (← links)
• STAT3 pathway regulates lung-derived brain metastasis initiating cell capacity through miR-21 activation. (Q35757920) (← links)
• Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma (Q35761986) (← links)
• Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth (Q35824820) (← links)
• A novel nuclear Src and p300 signaling axis controls migratory and invasive behavior in pancreatic cancer (Q35875878) (← links)
• CD133 brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence (Q36172819) (← links)
• Identification of a natural product-like STAT3 dimerization inhibitor by structure-based virtual screening (Q36179596) (← links)
• High Glucose-Mediated STAT3 Activation in Endometrial Cancer Is Inhibited by Metformin: Therapeutic Implications for Endometrial Cancer (Q36257678) (← links)
• Regulation of the JMJD3 (KDM6B) histone demethylase in glioblastoma stem cells by STAT3 (Q36338775) (← links)
• Inhibition of STAT3 activity delays obesity-induced thyroid carcinogenesis in a mouse model (Q36351206) (← links)
• Hydroxamic Acid and Benzoic Acid-Based STAT3 Inhibitors Suppress Human Glioma and Breast Cancer Phenotypes In Vitro and In Vivo (Q36385313) (← links)
• Identification of novel small molecules that inhibit STAT3-dependent transcription and function. (Q36411459) (← links)
• IL-17A/IL-17RA interaction promoted metastasis of osteosarcoma cells (Q36608717) (← links)
• Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation. (Q36619740) (← links)
• Discovery of O-Alkylamino Tethered Niclosamide Derivatives as Potent and Orally Bioavailable Anticancer Agents (Q36641981) (← links)
• Ezh2 Controls an Early Hematopoietic Program and Growth and Survival Signaling in Early T Cell Precursor Acute Lymphoblastic Leukemia (Q36682938) (← links)
• Carcinoembryonic Antigen Cell Adhesion Molecule 1 long isoform modulates malignancy of poorly differentiated colon cancer cells. (Q36782872) (← links)
• Applying Small Molecule Signal Transducer and Activator of Transcription-3 (STAT3) Protein Inhibitors as Pancreatic Cancer Therapeutics (Q36918125) (← links)
• A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway (Q36962588) (← links)
• Diet-induced obesity increases tumor growth and promotes anaplastic change in thyroid cancer in a mouse model (Q37018515) (← links)